Your browser doesn't support javascript.
loading
Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function.
Duquenne, Manon; Folgueira, Cintia; Bourouh, Cyril; Millet, Marion; Silva, Anisia; Clasadonte, Jérôme; Imbernon, Monica; Fernandois, Daniela; Martinez-Corral, Ines; Kusumakshi, Soumya; Caron, Emilie; Rasika, S; Deliglia, Eleonora; Jouy, Nathalie; Oishi, Asturo; Mazzone, Massimiliano; Trinquet, Eric; Tavernier, Jan; Kim, Young-Bum; Ory, Stéphane; Jockers, Ralf; Schwaninger, Markus; Boehm, Ulrich; Nogueiras, Ruben; Annicotte, Jean-Sébastien; Gasman, Stéphane; Dam, Julie; Prévot, Vincent.
Affiliation
  • Duquenne M; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.
  • Folgueira C; Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Bourouh C; CIBER Fisiopatología de la Obesidad y Nutrición, Santiago de Compostela, Spain.
  • Millet M; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, CNRS, U1283-UMR 8199-EGID, Lille, France.
  • Silva A; Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France.
  • Clasadonte J; Institut Cochin, Inserm U1016, CNRS UMR 8104, University Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • Imbernon M; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.
  • Fernandois D; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.
  • Martinez-Corral I; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.
  • Kusumakshi S; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.
  • Caron E; Experimental Pharmacology, Center for Molecular Signaling, Saarland University School of Medicine, Homburg, Germany.
  • Rasika S; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.
  • Deliglia E; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.
  • Jouy N; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.
  • Oishi A; Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.
  • Mazzone M; Flow Cytometry Core Facility, BioImaging Center of Lille, Hospital Campus, UMS2014-US41, Lille, France.
  • Trinquet E; Institut Cochin, Inserm U1016, CNRS UMR 8104, University Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • Tavernier J; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Department of Oncology, Leuven, Belgium.
  • Kim YB; Cisbio Bioassays, Parc Technologique Marcel Boiteux, Codolet, France.
  • Ory S; VIB-UGent Center for Medical Biotechnology, Gent, Belgium.
  • Jockers R; Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • Schwaninger M; Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France.
  • Boehm U; Institut Cochin, Inserm U1016, CNRS UMR 8104, University Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • Nogueiras R; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany.
  • Annicotte JS; Experimental Pharmacology, Center for Molecular Signaling, Saarland University School of Medicine, Homburg, Germany.
  • Gasman S; Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Dam J; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, CNRS, U1283-UMR 8199-EGID, Lille, France.
  • Prévot V; Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France.
Nat Metab ; 3(8): 1071-1090, 2021 08.
Article in En | MEDLINE | ID: mdl-34341568
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreas / Brain / Leptin / Lipid Metabolism / Receptors, Leptin / Ependymoglial Cells / ErbB Receptors Type of study: Etiology_studies / Prognostic_studies Language: En Journal: Nat Metab Year: 2021 Document type: Article Affiliation country: Francia Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreas / Brain / Leptin / Lipid Metabolism / Receptors, Leptin / Ependymoglial Cells / ErbB Receptors Type of study: Etiology_studies / Prognostic_studies Language: En Journal: Nat Metab Year: 2021 Document type: Article Affiliation country: Francia Country of publication: Alemania